DONALD J HAYDEN JR Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DONALD J HAYDEN JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DONALD J HAYDEN JR. DONALD J HAYDEN JR is EVP and President, Americas in BRISTOL MYERS SQUIBB CO ($BMY) and Director in INSMED Inc ($INSM) and Director in AMICUS THERAPEUTICS INC ($FOLD) and Director in Vitae Pharmaceuticals, Inc ($VTAE) and in REGENXBIO Inc. ($RGNX) and Director in REGENXBIO Inc. ($RGNX).
Latest Insider Trading Transactions of DONALD J HAYDEN JR
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FOLD, BMY, INSM, RGNX, VTAE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 02 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | A | 37.66 | 10,000 | 376,600 | 10,000 | ||
| Feb 12 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 24,800 | 21,080 | 129,100 | ||
| Feb 12 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 50.11 | 24,800 | 1,242,728 | 0 | 24.8 K to 0 (-100.00 %) | |
| Feb 12 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 24,800 | 21,080 | 24,800 | 0 to 24.8 K | |
| Feb 07 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 2,000 | 1,700 | 153,900 | ||
| Feb 07 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 50.00 | 2,000 | 100,000 | 0 | 2 K to 0 (-100.00 %) | |
| Feb 07 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 2,000 | 1,700 | 2,000 | 0 to 2 K | |
| Jan 21 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 3,200 | 2,720 | 155,900 | ||
| Jan 21 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 50.01 | 3,200 | 160,032 | 0 | 3.2 K to 0 (-100.00 %) | |
| Jan 21 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 3,200 | 2,720 | 3,200 | 0 to 3.2 K | |
| Jan 16 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 30,000 | 25,500 | 159,100 | ||
| Jan 16 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 45.60 | 30,000 | 1,368,000 | 0 | 30 K to 0 (-100.00 %) | |
| Jan 16 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 30,000 | 25,500 | 30,000 | 0 to 30 K | |
| Jun 04 2019 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | A | 43.02 | 10,000 | 430,200 | 10,000 | ||
| Apr 11 2019 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Option Exercise | M | 3.03 | 6,286 | 19,047 | 3,714 | |
| Apr 11 2019 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Sell | S | 32.99 | 6,286 | 207,375 | 62,197 | 68.5 K to 62.2 K (-9.18 %) |
| Apr 11 2019 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Buy | M | 3.03 | 6,286 | 19,047 | 68,483 | 62.2 K to 68.5 K (+10.11 %) |
| Feb 26 2019 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Option Exercise | M | 3.03 | 14,900 | 45,147 | 10,100 | |
| Feb 26 2019 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Sell | S | 28.08 | 14,900 | 418,392 | 62,197 | 77.1 K to 62.2 K (-19.33 %) |
| Feb 26 2019 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Buy | M | 3.03 | 14,900 | 45,147 | 77,097 | 62.2 K to 77.1 K (+23.96 %) |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 16.23 | 8,912 | 144,642 | 8,912 | |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Grant | A | 0.00 | 3,081 | 0 | 8,895 | 5.8 K to 8.9 K (+52.99 %) |
| Jun 05 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 14,900 | 12,665 | 189,100 | ||
| Jun 05 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 100 | 85 | 204,000 | ||
| Jun 05 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 55.01 | 14,900 | 819,649 | 0 | 14.9 K to 0 (-100.00 %) | |
| Jun 05 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 14,900 | 12,665 | 14,900 | 0 to 14.9 K | |
| Jun 05 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 55.00 | 100 | 5,500 | 0 | 100 to 0 (-100.00 %) | |
| Jun 05 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 100 | 85 | 100 | 0 to 100 | |
| May 30 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | A | 49.45 | 12,500 | 618,125 | 12,500 | ||
| May 16 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 9,847 | 8,370 | 204,100 | ||
| May 16 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 5,153 | 4,380 | 213,947 | ||
| May 16 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 50.06 | 9,847 | 492,941 | 0 | 9.8 K to 0 (-100.00 %) | |
| May 16 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 9,847 | 8,370 | 9,847 | 0 to 9.8 K | |
| May 16 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 50.04 | 5,153 | 257,856 | 0 | 5.2 K to 0 (-100.00 %) | |
| May 16 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 5,153 | 4,380 | 5,153 | 0 to 5.2 K | |
| May 11 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 15,000 | 12,750 | 219,100 | ||
| May 11 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 45.00 | 15,000 | 675,000 | 0 | 15 K to 0 (-100.00 %) | |
| May 11 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 15,000 | 12,750 | 15,000 | 0 to 15 K | |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 10.53 | 10,000 | 105,300 | 0 | |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 7.15 | 10,000 | 71,500 | 0 | |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Sell | S | 15.00 | 20,000 | 300,002 | 5,814 | 25.8 K to 5.8 K (-77.48 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Buy | M | 15.00 | 20,000 | 300,002 | 25,814 | 5.8 K to 25.8 K (+344.00 %) |
| Nov 16 2017 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Option Exercise | M | 3.03 | 15,000 | 45,450 | 25,000 | |
| Nov 16 2017 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Sell | S | 32.50 | 15,000 | 487,500 | 56,131 | 71.1 K to 56.1 K (-21.09 %) |
| Nov 16 2017 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Buy | M | 3.03 | 15,000 | 45,450 | 71,131 | 56.1 K to 71.1 K (+26.72 %) |
| Oct 13 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 20,000 | 17,000 | 234,100 | ||
| Oct 13 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 34.95 | 20,000 | 699,000 | 0 | 20 K to 0 (-100.00 %) | |
| Oct 13 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 20,000 | 17,000 | 20,000 | 0 to 20 K | |
| Sep 29 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 20,000 | 17,000 | 254,100 | ||
| Sep 29 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 32.45 | 20,000 | 649,000 | 0 | 20 K to 0 (-100.00 %) | |
| Sep 29 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 20,000 | 17,000 | 20,000 | 0 to 20 K | |
| Sep 19 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 20,000 | 17,000 | 274,100 | ||
| Sep 19 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 20,000 | 17,000 | 294,100 | ||
| Sep 19 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 29.95 | 20,000 | 599,000 | 0 | 20 K to 0 (-100.00 %) | |
| Sep 19 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 20,000 | 17,000 | 20,000 | 0 to 20 K | |
| Sep 19 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 27.45 | 20,000 | 549,000 | 0 | 20 K to 0 (-100.00 %) | |
| Sep 19 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 20,000 | 17,000 | 20,000 | 0 to 20 K | |
| Sep 07 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 20,000 | 17,000 | 314,100 | ||
| Sep 07 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 24.95 | 20,000 | 499,000 | 0 | 20 K to 0 (-100.00 %) | |
| Sep 07 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 20,000 | 17,000 | 20,000 | 0 to 20 K | |
| Sep 07 2017 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Option Exercise | M | 3.03 | 15,000 | 45,450 | 40,000 | |
| Sep 07 2017 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Option Exercise | M | 3.03 | 15,000 | 45,450 | 55,000 | |
| Sep 07 2017 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Option Exercise | M | 3.03 | 15,000 | 45,450 | 70,000 | |
| Sep 07 2017 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Sell | S | 30.00 | 15,000 | 450,000 | 56,131 | 71.1 K to 56.1 K (-21.09 %) |
| Sep 07 2017 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Buy | M | 3.03 | 15,000 | 45,450 | 71,131 | 56.1 K to 71.1 K (+26.72 %) |
| Sep 07 2017 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Sell | S | 29.50 | 15,000 | 442,500 | 56,131 | 71.1 K to 56.1 K (-21.09 %) |
| Sep 07 2017 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Buy | M | 3.03 | 15,000 | 45,450 | 71,131 | 56.1 K to 71.1 K (+26.72 %) |
| Sep 07 2017 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Sell | S | 29.50 | 15,000 | 442,500 | 56,131 | 71.1 K to 56.1 K (-21.09 %) |
| Sep 07 2017 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Buy | M | 3.03 | 15,000 | 45,450 | 71,131 | 56.1 K to 71.1 K (+26.72 %) |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 8.60 | 16,236 | 139,630 | 16,236 | |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Grant | A | 0.00 | 5,814 | 0 | 5,814 | 0 to 5.8 K |
| May 26 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Director | Option Exercise | A | 18.85 | 12,500 | 235,625 | 12,500 | |
| May 19 2017 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Grant | A | 0.00 | 6,702 | 0 | 56,131 | 49.4 K to 56.1 K (+13.56 %) |
| May 10 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Director | Sell | S | 18.35 | 10,000 | 183,500 | 8,599 | 18.6 K to 8.6 K (-53.77 %) |
| May 03 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Director | Option Exercise | M | 0.85 | 20,000 | 17,000 | 251,382 | |
| May 03 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Director | Sell | S | 22.43 | 25,262 | 566,627 | 18,599 | 43.9 K to 18.6 K (-57.60 %) |
| May 03 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Director | Sell | S | 21.34 | 4,738 | 101,109 | 43,861 | 48.6 K to 43.9 K (-9.75 %) |
| May 03 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Director | Buy | M | 0.85 | 20,000 | 17,000 | 48,599 | 28.6 K to 48.6 K (+69.93 %) |
| Apr 26 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Director | Sell | S | 20.98 | 10,000 | 209,800 | 28,599 | 38.6 K to 28.6 K (-25.91 %) |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | D | 9.62 | 10,000 | 96,200 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | D | 12.43 | 10,000 | 124,300 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | D | 8.00 | 17,000 | 136,000 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | D | 5.29 | 18,182 | 96,183 | 0 | |
| Jun 13 2016 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 6.71 | 20,000 | 134,200 | 20,000 | |
| Jun 02 2016 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Director | Option Exercise | A | 12.74 | 12,500 | 159,250 | 12,500 | |
| May 27 2016 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 9.62 | 10,000 | 96,200 | 10,000 | |
| May 23 2016 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Grant | A | 0.00 | 12,742 | 0 | 49,429 | 36.7 K to 49.4 K (+34.73 %) |
| Mar 21 2016 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 3.45 | 14,195 | 48,973 | 0 | |
| Mar 21 2016 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 3.45 | 1,935 | 6,676 | 0 | |
| Mar 21 2016 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Sell | S | 7.42 | 16,130 | 119,685 | 0 | 16.1 K to 0 (-100.00 %) |
| Mar 21 2016 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Buy | M | 3.45 | 14,195 | 48,973 | 14,195 | 0 to 14.2 K |
| Mar 21 2016 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Buy | M | 3.45 | 1,935 | 6,676 | 1,935 | 0 to 1.9 K |
| Dec 30 2015 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 3.45 | 16,130 | 55,649 | 1,935 | |
| Dec 30 2015 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Sell | S | 18.00 | 16,130 | 290,340 | 0 | 16.1 K to 0 (-100.00 %) |
| Dec 30 2015 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Buy | M | 3.45 | 16,130 | 55,649 | 16,130 | 0 to 16.1 K |
| Sep 22 2015 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 3.45 | 16,130 | 55,649 | 18,065 | |
| Sep 22 2015 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Sell | S | 17.00 | 16,130 | 274,210 | 0 | 16.1 K to 0 (-100.00 %) |
| Sep 22 2015 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Buy | M | 3.45 | 16,130 | 55,649 | 16,130 | 0 to 16.1 K |
| Sep 22 2015 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Director | Option Exercise | C | 0.00 | 38,599 | 0 | 0 | |
| Sep 22 2015 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Director | Buy | C | 0.00 | 38,599 | 0 | 38,599 | 0 to 38.6 K |
| Sep 17 2015 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Director | Option Exercise | A | 22.00 | 5,208 | 114,576 | 5,208 | |
| Sep 03 2015 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Sell | S | 24.08 | 9,252 | 222,742 | 36,687 | 45.9 K to 36.7 K (-20.14 %) |
| Sep 03 2015 | INSM | INSMED Inc | HAYDEN DONALD J JR | Director | Sell | S | 24.05 | 15,748 | 378,702 | 45,939 | 61.7 K to 45.9 K (-25.53 %) |
| Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 2.80 | 15,000 | 42,000 | 0 | |
| Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 3.32 | 15,000 | 49,800 | 0 | |
| Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 4.79 | 15,000 | 71,850 | 0 | |
| Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 2.81 | 10,000 | 28,100 | 0 | |
| Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Sell | S | 14.01 | 55,000 | 770,391 | 0 | 55 K to 0 (-100.00 %) |
| Jun 24 2015 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Buy | M | 14.01 | 55,000 | 770,391 | 55,000 | 0 to 55 K |
| Jun 12 2015 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 13.09 | 20,000 | 261,800 | 20,000 | |
| Jun 01 2015 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 12.43 | 10,000 | 124,300 | 10,000 | |
| May 22 2015 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Option Exercise | M | 3.45 | 20,000 | 69,000 | 14,195 | |
| May 22 2015 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Sell | S | 12.01 | 20,000 | 240,200 | 0 | 20 K to 0 (-100.00 %) |
| May 22 2015 | VTAE | Vitae Pharmaceutic ... | HAYDEN DONALD J JR | Director | Buy | M | 3.45 | 20,000 | 69,000 | 20,000 | 0 to 20 K |
| Mar 03 2005 | BMY | BRISTOL MYERS SQUI ... | HAYDEN DONALD J JR | EVP and President, ... | Option Exercise | A | 25.45 | 100,000 | 2,545,000 | 100,000 | |
| Mar 03 2005 | BMY | BRISTOL MYERS SQUI ... | HAYDEN DONALD J JR | EVP and President, ... | Grant | A | 0.00 | 16,667 | 0 | 207,649 | 191 K to 207.6 K (+8.73 %) |
| Dec 03 2004 | BMY | BRISTOL MYERS SQUI ... | HAYDEN DONALD J JR | EVP and President, ... | Payment of Exercise | F | 23.64 | 5,174 | 122,313 | 190,982 | 196.2 K to 191 K (-2.64 %) |
| Mar 04 2004 | BMY | BRISTOL MYERS SQUI ... | HAYDEN DONALD J JR | EVP and President, ... | Option Exercise | A | 28.11 | 110,000 | 3,092,100 | 110,000 | |
| Mar 04 2004 | BMY | BRISTOL MYERS SQUI ... | HAYDEN DONALD J JR | EVP and President, ... | Grant | A | 0.00 | 18,333 | 0 | 196,156 | 177.8 K to 196.2 K (+10.31 %) |
| Mar 04 2004 | BMY | BRISTOL MYERS SQUI ... | HAYDEN DONALD J JR | EVP and President, ... | Option Exercise | A | 28.11 | 110,000 | 3,092,100 | 110,000 | |
| Mar 04 2004 | BMY | BRISTOL MYERS SQUI ... | HAYDEN DONALD J JR | EVP and President, ... | Grant | A | 0.00 | 18,333 | 0 | 196,156 | 177.8 K to 196.2 K (+10.31 %) |
| Mar 04 2004 | BMY | BRISTOL MYERS SQUI ... | HAYDEN DONALD J JR | EVP and President, ... | Option Exercise | A | 28.11 | 110,000 | 3,092,100 | 110,000 | |
| Mar 04 2004 | BMY | BRISTOL MYERS SQUI ... | HAYDEN DONALD J JR | EVP and President, ... | Grant | A | 0.00 | 18,333 | 0 | 196,156 | 177.8 K to 196.2 K (+10.31 %) |
| Mar 04 2004 | BMY | BRISTOL MYERS SQUI ... | HAYDEN DONALD J JR | EVP and President, ... | Option Exercise | A | 28.11 | 110,000 | 3,092,100 | 110,000 | |
| Mar 04 2004 | BMY | BRISTOL MYERS SQUI ... | HAYDEN DONALD J JR | EVP and President, ... | Grant | A | 0.00 | 18,333 | 0 | 196,156 | 177.8 K to 196.2 K (+10.31 %) |
| Dec 02 2003 | BMY | BRISTOL MYERS SQUI ... | HAYDEN DONALD J JR | EVP and President, ... | Payment of Exercise | F | 26.63 | 5,127 | 136,532 | 177,823 | 183 K to 177.8 K (-2.80 %) |
| Sep 12 2003 | BMY | BRISTOL MYERS SQUI ... | HAYDEN DONALD J JR | EVP and President, ... | Grant | A | 0.00 | 50,000 | 0 | 182,950 | 133 K to 183 K (+37.61 %) |
Page: 1